Literature DB >> 10484312

Preparation of extremely obese patients for laparoscopic gastric banding by gastric-balloon therapy.

R Weiner1, H Gutberlet, H Bockhorn.   

Abstract

BACKGROUND: In super, super obese patients (body mass index [BMI] >60), especially those with extreme intra-abdominal fat deposition, the technical difficulties in laparoscopic procedures increase. The purpose of this study was to evaluate whether gastric balloon therapy (GBT) can improve the operative conditions for laparoscopic adjustable gastric banding (LAGB) in extremely obese patients.
MATERIALS AND METHODS: From April 1995 to August 1998, 196 LAGBs were performed. In 15 patients (7 female and 8 male), median age 38.8 years (range 17-54), who had been selected as suitable candidates for bariatric surgery, preoperative GBT was studied. Fourteen patients were extremely obese (BMI 60.2 kg/m2 [range 58-72]). One 17-year-old boy with BMI 46.6 kg/m2 was also treated. The Bioenterics Intragastric Balloon (BIB) was used. The placement, the volume modification, and the removal of the BIB were performed endoscopically. Close follow-up was possible in 14 patients. After balloon removal, 13 patients underwent LAGB.
RESULTS: In 14 of 15 cases, GBT was successful. There was only one ballon dysfunction. The mean weight loss was 18.1 kg, and the median duration of balloon therapy was 16.8 weeks. After balloon removal, body weight started to increase.
CONCLUSIONS: In our experience, the gastric balloon can improve the conditions for laparoscopic surgery in super and in super, super obese patients. There was no conversion to open surgery. The effect of weight loss is much less than immediately after LAGB. However, after failure of all conservative treatments to reduce the preoperative body weight, the GBT seems to be the last possibility.

Entities:  

Mesh:

Year:  1999        PMID: 10484312     DOI: 10.1381/096089299765553133

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  26 in total

Review 1.  Evidence-based review of the Bioenterics intragastric balloon for weight loss.

Authors:  Jean-Marc Dumonceau
Journal:  Obes Surg       Date:  2008-06-21       Impact factor: 4.129

2.  Treatment with sibutramine prior to Roux-en-Y gastric bypass leads to an improvement of metabolic parameters and to a reduction of liver size and operative time.

Authors:  Jens Aberle; Anna Freier; Philipp Busch; Nina Mommsen; Frank U Beil; Viola Dannheim; Oliver Mann
Journal:  Obes Surg       Date:  2009-08-27       Impact factor: 4.129

3.  Air-filled vs water-filled intragastric balloon: a prospective randomized study.

Authors:  Cristiano Giardiello; Alessandro Borrelli; Eufemia Silvestri; Valentina Antognozzi; Giuseppe Iodice; Michele Lorenzo
Journal:  Obes Surg       Date:  2012-12       Impact factor: 4.129

4.  One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K.

Authors:  J Brooks; E D Srivastava; E M H Mathus-Vliegen
Journal:  Obes Surg       Date:  2014-05       Impact factor: 4.129

5.  Laparoscopic gastric bypass vs. sleeve gastrectomy in the super obese patient: early outcomes of an observational study.

Authors:  Carlos Zerrweck; Elisa M Sepúlveda; Hernán G Maydón; Francisco Campos; Antonio G Spaventa; Verónica Pratti; Itzel Fernández
Journal:  Obes Surg       Date:  2014-05       Impact factor: 4.129

6.  Intragastric balloon reduces liver volume in super-obese patients, facilitating subsequent laparoscopic gastric bypass.

Authors:  Maria Dolores Frutos; Maria Dolores Morales; Juan Luján; Quiteria Hernández; Graciela Valero; Pascual Parrilla
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

7.  Analysis of safety and efficacy of intragastric balloon in extremely obese patients.

Authors:  Stephan Göttig; Markos Daskalakis; Sylvia Weiner; Rudolf A Weiner
Journal:  Obes Surg       Date:  2009-03-17       Impact factor: 4.129

Review 8.  Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis.

Authors:  Iñaki Imaz; Carmen Martínez-Cervell; Elvira Elena García-Alvarez; Juan Manuel Sendra-Gutiérrez; Jesús González-Enríquez
Journal:  Obes Surg       Date:  2008-05-06       Impact factor: 4.129

9.  Six months of balloon treatment does not predict the success of gastric banding.

Authors:  Suzan de Goederen-van der Meij; Robert G J M Pierik; Marco Oudkerk Pool; Dirk J Gouma; Lisbeth M Mathus-Vliegen
Journal:  Obes Surg       Date:  2007-01       Impact factor: 4.129

10.  Safety of the Ullorex oral intragastric balloon for the treatment of obesity.

Authors:  Corby K Martin; Drake E Bellanger; Kristina K Rau; Sandra Coulon; Frank L Greenway
Journal:  J Diabetes Sci Technol       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.